Stockreport

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer [Yahoo! Finance]

Foghorn Therapeutics Inc.  (FHTX) 
PDF a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Kristian Humer will join the company as Chief Financial [Read more]